Evaluation of the effectiveness and safety of upadacitinib in the treatment of idiopathic refractory anterior scleritis: A case series study
The treatment of refractory anterior scleritis could be challenging with some patients not responding to conventional therapies such as systemic corticosteroid and immunosuppressive agents. The purpose of this study was to evaluate the effectiveness and safety of upadacitinib, a selective Janus kinase inhibitor (JAK-i)...